Literature DB >> 8763182

Antibiotic prophylaxis for infantile pyloromyotomy.

S Nour1, A E MacKinnon, J A Dickson, J Walker.   

Abstract

A retrospective study of 50 patients with infantile hypertrophic pyloric stenosis (IHPS) showed wound infection in six patients. In an attempt to assess the value of antibiotic prophylaxis in infantile pyloromyotomy 150 patients with infantile hypertrophic pyloric stenosis were entered in a prospective randomized controlled study. The infants were allocated to receive a dose of Cefuroxime (30 mg/kg) at induction of anaesthesia or no antibiotic. Eight infants developed wound infection, five in the control group and three in the antibiotic prophylaxis group. Although the difference between the two groups was not statistically significant there was an overall reduction of wound infection (6.5%) compared with pre-trial figures (12%). In order to study the bacterial flora in the umbilicus in these infants, culture swabs were taken from the umbilicus on admission, immediately prior to surgery and from the wound prior to skin closure. It was shown that the umbilicus was not the source of infection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8763182

Source DB:  PubMed          Journal:  J R Coll Surg Edinb        ISSN: 0035-8835


  3 in total

1.  Antibiotic Prophylaxis for Pyloromyotomy in Children: An Opportunity for Better Stewardship.

Authors:  Kibileri Williams; Timothy Lautz; Richard J Hendrickson; Tolulope A Oyetunji
Journal:  World J Surg       Date:  2018-12       Impact factor: 3.352

2.  Surgical site infections in neonates and infants: is antibiotic prophylaxis needed for longer than 24 h?

Authors:  Lan T Vu; Eric Vittinghoff; Kerilyn K Nobuhara; Diana L Farmer; Hanmin Lee
Journal:  Pediatr Surg Int       Date:  2014-05-09       Impact factor: 1.827

3.  Pyloromyotomy through circumbilical incision with fascial extension.

Authors:  V Karri; N Bouhadiba; A B Mathur
Journal:  Pediatr Surg Int       Date:  2003-10-29       Impact factor: 1.827

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.